Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bloating During the Menopause Transition: Observations from the Seattle Midlife Women's Health Study.

Journal of women's health (2002)·2026
Same author

Correction to: Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis.

The American journal of gastroenterology·2026
Same author

Patient Experience, Gender, Age, Race, and Social Determinants of Health.

Gastroenterology·2026
Same author

Relationship Between Heart Rate Variability and Sleep Among Girls and Boys With Abdominal Pain-Related Disorders of Gut-Brain Interaction.

Neurogastroenterology and motility·2026
Same author

Gastric Emptying, Colon Filling, and Multiregional Gut Transit Delays Are Prevalent on Glucagon-Like Peptide-1 Agonists.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

From Promise to Practice: The Practical Buyer's Guide to AI-Enabled Chronic Care Management.

American journal of health promotion : AJHP·2025

Related Experiment Videos

Practical considerations for recognizing and managing severe irritable bowel syndrome.

Lucinda A Harris1, Margaret M Heitkemper

  • 1Division of Gastroenterology, Mayo Clinic School of Medicine, Scottsdale, Arizona 85259, USA. Harris.Lucinda@mayo.edu

Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates
|February 7, 2012
PubMed
Summary

Nurses play a vital role in managing severe Irritable Bowel Syndrome (IBS). Comprehensive nursing assessments and patient dialogues improve recognition, treatment, and outcomes for IBS patients.

Related Experiment Videos

Area of Science:

  • Gastroenterology
  • Nursing Care

Background:

  • Irritable Bowel Syndrome (IBS) is a prevalent gastrointestinal disorder more common in women, often presenting with abdominal pain and altered bowel habits.
  • Severe IBS, characterized by poor treatment response or significant quality of life impairment, is frequently underrecognized and inadequately managed.
  • No universal definition for severe IBS exists, complicating clinical identification and management strategies.

Purpose of the Study:

  • To highlight the crucial role of nurses in the evaluation and management of patients with severe Irritable Bowel Syndrome (IBS).
  • To emphasize the importance of thorough nursing assessments in identifying predominant symptoms and treatment histories.
  • To underscore the value of nurse-patient dialogue in selecting appropriate therapies and improving patient outcomes.

Main Methods:

  • Nursing assessments focusing on symptom presentation, history of interventions (lifestyle, medications, psychotherapy, alternative treatments), and patient responses.
  • Evaluation of symptom severity and impact on daily functioning to guide therapeutic choices.
  • Facilitating nurse-patient dialogue regarding available treatment options, including benefits and risks.

Main Results:

  • Detailed nursing assessments are essential for effective IBS management.
  • Understanding symptom impact on daily life aids in personalized treatment selection.
  • Open communication between nurses and patients about treatment options enhances care.

Conclusions:

  • Nurses are key resources for optimizing the care of individuals with severe IBS.
  • Systematic nursing assessments and patient-centered communication can improve IBS recognition and management.
  • Enhanced nursing involvement can mitigate the negative effects of IBS and improve overall patient outcomes.